Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
The Journal of Biological Chemistry|March 15, 2006
Release of hypoacetylated and trimethylated histone H4 is an epigenetic marker of early apoptosisManuel Boix-Chornet, Mario F Fraga, Ana Villar-Garea, et al.Journal of Cell Science|July 25, 2007
Combinatorial effects of splice variants modulate function of AiolosRosalia Caballero, Fernando Setien, Lidia Lopez-Serra, et al.Nature Genetics|April 28, 2006
A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibitionSantiago Ropero, Mario F Fraga, Esteban Ballestar, et al.Breast Cancer Research : BCR|April 15, 2014
Clinical validation of the EndoPredict test in node-positive, chemotherapy-treated ER+/HER2- breast cancer patients: results from the GEICAM 9906 trialMiguel Martin, Jan C Brase, Lourdes Calvo, et al.The Oncologist|January 21, 2016
High Proliferation Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Early Breast CancerEmilio Alba, Ana Lluch, Nuria Ribelles, et al.Cancers|November 13, 2021
Pembrolizumab Plus Gemcitabine in the Subset of Triple-Negative Advanced Breast Cancer Patients in the GEICAM/2015-04 (PANGEA-Breast) StudyLuis de la Cruz-Merino, María Gion, Josefina Cruz-Jurado, et al.Nutrients|October 17, 2020
Serum Phospholipids Fatty Acids and Breast Cancer Risk by Pathological SubtypeVirginia Lope, Ángel Guerrero-Zotano, Ana Casas, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2025
FOXC1 Expression Predicts Capecitabine Efficacy in Patients with Triple-Negative Breast Cancer from the GEICAM_CIBOMA TrialFederico Rojo, Clive R Taylor, Carlos Barrios, et al.The Oncologist|April 25, 2015
Defining breast cancer intrinsic subtypes by quantitative receptor expressionMaggie C U Cheang, Miguel Martin, Torsten O Nielsen, et al.Pageof 1